Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, has signed an extension to its licensing agreement with Haselmeier, a company of the medmix group, for its Axis-D pen injector technology. The extension gives the company exclusivity to offer the technology to support a broader range of drugs for its biopharma customers beyond diabetes, including therapeutic areas such as obesity, ca...